Day One Biopharmaceuticals, Inc.

NASDAQ:DAWN

12.79 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 422.765239.616270.391230.784241.179189.21149.26885.262120.864388.877262.731284.309297.16309.996154.8743.7280
Short Term Investments 135.618122.2547.553135.563164.359253.671268.911257.007253.4775.9870000000
Cash and Short Term Investments 558.383361.866317.944366.347405.538442.882318.179342.269374.341394.864262.731284.309297.16309.996154.8743.72827.332
Net Receivables 8.6959.136000000000000000
Inventory 2.7350.151000000000000000
Other Current Assets 11.18312.0058.098.9277.7536.9024.2095.6056.1727.6394.6375.0596.1516.0290.1151.3430
Total Current Assets 580.996383.158326.034375.274405.538449.784322.388347.874380.513402.503267.368289.368303.311316.025158.75545.07127.332
Non-Current Assets:
Property, Plant & Equipment, Net 3.4780.360.4440.560.6550.7130.6880.7190.8991.060.2460.2840.3350.3860.4350.4830
Goodwill 00000000000000000
Intangible Assets 16.21616.802000000000000000
Goodwill and Intangible Assets 16.21616.802000000000000000
Long Term Investments 00000000000000000
Tax Assets 00000000000000000
Other Non-Current Assets 0.1170.1170.1670.2147.9860.2590.4870.4690.4490.4840.1650.1690.1370.1261.690.107-27.332
Total Non-Current Assets 19.81117.2790.6110.7748.6410.9721.1751.1881.3481.5440.4110.4530.4720.5122.1250.59-27.332
Total Assets 600.807400.437326.645376.048414.179450.756323.563349.062381.861404.047267.779289.821303.783316.537160.8845.6610
Liabilities & Equity:
Current Liabilities:
Account Payables 3.0176.4444.782.5763.3914.5654.6570.263.9730.4390.7011.7440.6830.3480.6860.2020
Short Term Debt 0.1540.380.30.8160.8740.8560.8340.4050.9240.8540.3420.2040.4040.4020.1990.1980
Tax Payables 00000000000000000
Deferred Revenue 1.4620025.48320.23819.33300011.77206.6054.9764.0192.1741.5690
Other Current Liabilities 35.11286.88224.75926.11620.2119.09117.35715.9513.37411.5067.1336.7094.9593.9122.1811.5960
Total Current Liabilities 39.74593.70629.83929.50824.47524.51222.84816.61518.27112.7998.1768.6576.0464.6623.0661.9960
Non-Current Liabilities:
Long Term Debt 2.5380000.0770.190.30.4080.5140.61700.0160.0650.1120.1590.2040
Deferred Revenue Non-Current 3.0610000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000
Other Non-Current Liabilities 00000000000000221.72191.964-25.318
Total Non-Current Liabilities 5.5990000.0770.190.30.4080.5140.6170.8720.0160.0650.112221.8892.168-25.318
Total Liabilities 45.34493.70629.83929.508818.25324.70223.14817.02318.78513.4168.1768.6736.1114.774224.94694.164-25.318
Equity:
Preferred Stock 000000000000303.78304.783030.504
Common Stock 0.010.0090.0090.0090.0090.0090.0070.0070.0070.0070.0060.0060.0060.006220
Retained Earnings -488.367-525.404-520.997-458.585-404.074-357.924-312.061-269.668-229.559-191.764-155.234-127.487-105.548-86.308-72.024-56.8420
Accumulated Other Comprehensive Income/Loss -0.006-0.022-0.0050.009-0.007-0.0090.067-0.071-0.392-0.00300-303.783000-10.673
Other Total Stockholders Equity 1,043.826832.148817.799805.107793.699783.978612.402601.771593.02582.391414.831408.629706.997398.065-3.60892.6015.487
Total Shareholders Equity 555.463306.731296.806346.54-404.074426.054-312.061332.039363.076390.631259.603-127.487297.672311.763-68.849-54.20525.318
Total Equity 555.463306.731296.806346.54-404.074426.054-312.061332.039363.076390.631259.6030000025.318
Total Liabilities & Shareholders Equity 600.807400.437326.645376.048414.179450.756-288.913349.062381.861404.047267.779-118.814303.783316.537160.8845.6610